ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM)
ASBPW0.02400.00% ( 0.0000 )
ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM) (ASBPW)
- Open
- 0.0185
- High
- --
- Low
- --
- Prev. Close
- 0.0240
- Volume
- 75
- Turnover
- 1.39
- Avg Price
- 0.0185
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 0.0822
- Volume Ratio
- 0.06
- Turnover Ratio
- 0.01%
News
- Unusual Whales · 23 hours ago
Norstella Launches Pipeline-to-Patient Productivity Index to Benchmark Biopharma Performance Across the Drug Development Lifecycle
- Unusual Whales · 2 days ago, 06:03 AM
CAMP4 Therapeutics Secures Australian Regulatory Clearance to Initiate First-in-Human Clinical Trial of CMP-002 in Patients With SYNGAP1-Related Disorder
- Tip Ranks · Jul 20 at 04:48 PM
Aspire Biopharma Updates Public Warrant Exercise Terms
- Earnings Watch · Apr 24 at 06:11 AM
ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM) | 10-K: FY2025 Revenue: USD 6.202 K
- Earnings Watch · Nov 14, 2025 at 07:24 AM
ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM) | 10-Q: FY2025 Q3 Revenue: USD 1.941 K
- Earnings Watch · Aug 13, 2025 at 04:04 PM
ASPIRE BIOPHARMA HOLDINGS INC C/WTS 14/02/2030 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD -0.41
